Second-quarter fiscal 2010 results announced by Peregrine Pharmaceuticals

[News]

Peregrine Pharmaceuticals, Inc. today announced financial results for the second quarter of fiscal year (FY) 2010 ended October 31, 2009. Total revenue for the second quarter of FY 2010 increased 255% to $6,896,000, compared to $1,941,000 for the comparable prior year quarter.

More... (http://www.news-medical.net/news/20091210/Second-quarter-fiscal-2010-results-announced-by-Peregrine-Pharmaceuticals.aspx)